Search
Methyl aminolevulinate
go.drugbank.com/drugs/DB00992ApprovedInvestigationalMethyl aminolevulinate is a prodrug that is metabolised to Protoporphyrin IX (a photosensitizer) used in photodynamic therapy.
Categories: Amino Acids, Peptides, and Proteins, Skin and Mucous Membrane AgentsProducts: Metvix 160mg/g CreamSodium zirconium cyclosilicate
go.drugbank.com/drugs/DB14048ApprovedInvestigationalSodium zirconium cyclosilicate is approved as the trade product Lokelma developed by AstraZeneca - an insoluble, non-absorbed sodium zirconium silicate, formulated as a powder for oral suspension that … [L2933] Approval of the medication is supported by data from three double-blind, placebo-controlled trials and two open-label trials which showed that the onset of action was approximately 1.0 hour and
Categories: Drugs for Treatment of Hyperkalemia and HyperphosphatemiaProducts: LOKELMA POWDER FOR ORAL SUSPENSION 10G, Lokelma 10g Powder for Oral SuspensionRifapentine
go.drugbank.com/drugs/DB01201ApprovedInvestigationalSpecifically, it interacts with bacterial RNA polymerase but does not inhibit the mammalian enzyme. … Rifapentine is an antibiotic drug used in the treatment of tuberculosis. It inhibits DNA-dependent RNA polymerase activity in susceptible cells.
Products: PRIFTIN FILM COATED TABLETS 150MGPergolide
go.drugbank.com/drugs/DB01186ApprovedVet approvedWithdrawnIt is an ergot derivative that acts on the dopamine D2 and D3, alpha2- and alpha1-adrenergic, and 5-hydroxytryptamine (5-HT) receptors. … The drug was withdrawn from the US market in March 2007 and from the Canadian market in August 2007.
Categories: Ergot Alkaloids and Derivatives, Serotonergic Drugs Shown to Increase Risk of Serotonin SyndromeProducts: Permax Tab 1mg, PERGOLID HEXAL 1MGFerric derisomaltose
go.drugbank.com/drugs/DB15617ApprovedInvestigationalFerric derisomaltose was developed by Pharmacosmos Therapeutics ad was granted FDA approval in January 2020. … This drug is a complex of iron (III) hydroxide and derisomaltose. The latter is an iron carbohydrate oligosaccharide that works to release iron.
Products: Monofer 100mg/ml solution for injection/infusion in ampoulesPectin
go.drugbank.com/drugs/DB11158ApprovedInvestigationalVet approvedThis status allows pectin to be used with no limitations.[L1960]
Mixtures: Kaolin and Pectin Susp, Cepacol Sore Throat and CoatingCategories: Alimentary Tract and Metabolism, Diet, Food, and NutritionMagnesium chloride
go.drugbank.com/drugs/DB09407ApprovedInvestigationalMagnesium chloride salts are highly soluble in water and the hydrated form of magnesium chloride can be extracted from brine or sea water.
Mixtures: Dextrose and Electrolyte No. 48, Plasma-Lyte 148 and dextroseCategories: Alimentary Tract and Metabolism, Blood and Blood Forming OrgansSulpiride
go.drugbank.com/drugs/DB00391ApprovedWithdrawn[A229683] Sulpiride is not approved by the FDA, Health Canada, or the EMA; though it is approved in individual European countries.[L24679] … [A229538] Clinical studies show a greater effect on treating the negative symptoms of schizophrenia rather than positive symptoms at low doses, though the effects are more equal at higher doses.
Categories: Benzamides and benzamide derivativesSynonyms: N-((1-Ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-o-anisamide, N-((1-Ethyl-2-pyrrolidinyl)methyl)-2-methoxy-5-sulfamoylbenzamideIpilimumab
go.drugbank.com/drugs/DB06186ApprovedInvestigational[L12126] Blocking CTLA-4 removes an inhibitory signal from reducing the activity of T lymphocytes.[A35065,A35080,L12126] Ipilimumab was developed by Bristol-Myers Squibb and Medarex. … [L12126] Ipilimumab was granted FDA approval on 25 March 2011.[L12126]
Categories: Amino Acids, Peptides, and Proteins, Antineoplastic and Immunomodulating AgentsProducts: YERVOY 50MG/10ML IV INFUZYONLUK ÇOZELTI KONSANTRESI ICEREN FLAKON, 1 ADET, YERVOY INJECTION CONCENTRATE 5MG/MLRaltegravir
go.drugbank.com/drugs/DB06817ApprovedInvestigationalRaltegravir is an antiretroviral drug produced by Merck & Co., used to treat HIV infection. It received approval by the U.S. … Food and Drug Administration (FDA) on 12 October 2007, the first of a new class of HIV drugs, the integrase inhibitors, to receive such approval.
Categories: lamivudine and raltegravirProducts: ISENTRESS® TABLETAS MASTICABLES 100MG